David Pendarvis Resmed Inc (RSMDF) insider trading activity

David Pendarvis is Chief Administrative Officer of RESMED INC. Currently has a direct ownership of 89,729 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Nov 18, 2021, when has been sold 986 shares (ResMed Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.7K

0% 3M change

0% 12M change

Total Value Held $0

DAVID PENDARVIS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2021	BUY Grant, award, or other acquisition	-	986 Added 0.82%	119,123 ResMed Common Stock
Nov 17 2021	SELL Payment of exercise price or tax liability	$2,460,191 $254.81 p/Share	9,655 Reduced 7.56%	118,137 ResMed Common Stock
Nov 16 2021	BUY Grant, award, or other acquisition	$4,409,997 $254.81 p/Share	17,307 Added 11.93%	127,792 ResMed Common Stock
Nov 11 2021	SELL Payment of exercise price or tax liability	$401,919 $259.47 p/Share	1,549 Reduced 1.28%	119,502 ResMed Common Stock
Nov 11 2021	SELL Bona fide gift	-	10,000 Reduced 8.3%	110,485 ResMed Common Stock
Nov 11 2021	BUY Exercise of conversion of derivative security	$99,912 $101.64 p/Share	983 Added 0.81%	120,485 ResMed Common Stock
Nov 03 2021	SELL Open market or private sale	$392,471 $264.29 p/Share	1,485 Reduced 1.21%	120,987 ResMed Common Stock
Oct 04 2021	SELL Open market or private sale	$387,795 $260.79 p/Share	1,487 Reduced 1.2%	122,472 ResMed Common Stock
Sep 03 2021	SELL Open market or private sale	$434,442 $292.16 p/Share	1,487 Reduced 1.19%	123,959 ResMed Common Stock
Aug 19 2021	BUY Grant, award, or other acquisition	-	2,033 Added 1.59%	125,446 ResMed Common Stock
Aug 03 2021	SELL Open market or private sale	$400,568 $269.38 p/Share	1,487 Reduced 1.19%	123,413 ResMed Common Stock
Jul 06 2021	SELL Open market or private sale	$367,467 $247.12 p/Share	1,487 Reduced 1.18%	124,900 ResMed Common Stock
Jun 03 2021	SELL Open market or private sale	$307,809 $207.0 p/Share	1,487 Reduced 1.16%	126,387 ResMed Common Stock
May 03 2021	SELL Open market or private sale	$283,274 $190.5 p/Share	1,487 Reduced 1.15%	127,807 ResMed Common Stock
Apr 05 2021	SELL Open market or private sale	$291,675 $196.15 p/Share	1,487 Reduced 1.14%	129,294 ResMed Common Stock
Mar 03 2021	SELL Open market or private sale	$285,207 $191.8 p/Share	1,487 Reduced 1.12%	130,781 ResMed Common Stock
Feb 03 2021	SELL Open market or private sale	$303,973 $204.42 p/Share	1,487 Reduced 1.11%	132,268 ResMed Common Stock
Jan 18 2021	BUY Grant, award, or other acquisition	-	1,548 Added 1.14%	133,755 ResMed Common Stock
Jan 04 2021	SELL Open market or private sale	$317,088 $213.24 p/Share	1,487 Reduced 1.11%	132,207 ResMed Common Stock
Dec 03 2020	SELL Open market or private sale	$309,831 $208.36 p/Share	1,487 Reduced 1.1%	133,694 ResMed Common Stock
Nov 23 2020	SELL Bona fide gift	-	10,000 Reduced 6.89%	135,181 ResMed Common Stock
Nov 20 2020	BUY Exercise of conversion of derivative security	$99,936 $84.98 p/Share	1,176 Added 0.8%	145,181 ResMed Common Stock
Nov 17 2020	SELL Payment of exercise price or tax liability	$2,672,439 $214.74 p/Share	12,445 Reduced 7.95%	144,005 ResMed Common Stock
Nov 17 2020	BUY Grant, award, or other acquisition	$4,790,850 $214.74 p/Share	22,310 Added 12.48%	156,450 ResMed Common Stock
Nov 11 2020	SELL Payment of exercise price or tax liability	$438,431 $212.11 p/Share	2,067 Reduced 1.52%	134,140 ResMed Common Stock

Also insider at

WDFC

WD 40 CO Basic Materials

David Pendarvis

Chief Administrative Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account